A Dark Vector Cognition product

Item 1. Financial Statements

94K characters. Original on sec.gov ·

Item 1. Financial Statements

The 37 tables in Item 1. Financial Statements as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net sales$2,220,306$1,892,641$6,193,140$5,402,668
Cost of sales1,409,8721,206,5053,930,1063,455,643
Selling, general and administrative225,485197,756634,956542,190
Total operating expenses1,635,3571,404,2614,565,0623,997,833
Operating income584,949488,3801,628,0781,404,835
Interest expense(39,822)(22,514)(90,832)(58,364)
Other (expense) income, net(23,212)(17,901)(29,979)(22,115)
Income before income taxes521,915447,9651,507,2671,324,356
Provision for income taxes95,61576,549274,714242,815
Net income$426,300$371,416$1,232,553$1,081,541
Basic earnings per share$1.86$1.61$5.38$4.69
Diluted earnings per share$1.85$1.60$5.36$4.67
Weighted average common shares outstanding:
Basic shares229,159230,733229,049230,740
Diluted shares230,040231,670229,910231,561
Dividends declared and paid per share$0.34$0.31$1.02$0.93

See accompanying notes.

AMETEK, Inc.

Consolidated Statement of Comprehensive Income

(In thousands)

(Unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net income$426,300$371,416$1,232,553$1,081,541
Other comprehensive income (loss):
Amounts arising during the period – gains (losses), net of tax (expense) benefit:
Foreign currency translation:
Translation adjustments49,514(34,294)(16,302)201,697
Change in long-term intercompany notes(1,628)144437(5,699)
Net investment hedge instruments gain (loss), net of tax of $(6,385) and $(2,022) for the quarter ended September 30, 2026 and 2025, and $(11,763) and $23,934 for the nine months ended September 30, 2026 and 2025, respectively20,3426,44137,478(76,253)
Defined benefit pension plans:
Amortization of net actuarial loss, net of tax of $(167) and $(296) for the quarter ended September 30, 2026 and 2025 and $(501) and $(888) for the nine months ended September 30, 2026 and 2025, respectively5319421,5932,826
Other comprehensive (loss) income68,759(26,767)23,206122,571
Total comprehensive income$495,059$344,649$1,255,759$1,204,112

AMETEK, Inc.

Consolidated Balance Sheet

(In thousands)

September 30, 2026December 31, 2025
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$666,152$457,951
Receivables, net1,348,4491,119,257
Inventories, net1,366,8451,106,405
Other current assets393,853336,229
Total current assets3,775,2993,019,842
Property, plant and equipment, net901,486855,215
Right of use assets, net284,603273,142
Goodwill10,210,7067,170,770
Other intangibles, net6,522,3004,128,394
Investments and other assets694,141620,180
Total assets$22,388,535$16,067,543
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings and current portion of long-term debt, net$639,822$1,208,975
Accounts payable731,615617,950
Customer advanced payments498,907396,177
Income taxes payable147,04782,682
Accrued liabilities and other620,835536,968
Total current liabilities2,638,2262,842,752
Long-term debt, net6,029,5651,074,334
Deferred income taxes1,240,187788,915
Other long-term liabilities784,349732,756
Total liabilities10,692,3275,438,757
Stockholders’ equity:
Common stock, $0.01 par value2,7292,725
Capital in excess of par value1,357,8911,317,288
Retained earnings13,251,49812,252,480
Accumulated other comprehensive loss(376,014)(399,220)
Treasury stock(2,539,896)(2,544,487)
Total stockholders’ equity11,696,20810,628,786
Total liabilities and stockholders’ equity$22,388,535$16,067,543

See accompanying notes.

AMETEK, Inc.

Consolidated Statement of Stockholders’ Equity

(In thousands)

(Unaudited)

Common stockCapital in excess of par valueRetained earningsAccumulated other comprehensive (loss) incomeTreasury stockTotal stockholders’ equity
Three Months Ended September 30, 2026
Balance at June 30, 2026$2,729$1,339,427$12,903,079$(444,773)$(2,539,699)$11,260,763
Net income——426,300——426,300
Shares issued——————
Issuance of common stock under employee stock plans—4,390——(149)4,241
Share-based compensation expense—14,074———14,074
Cash dividends paid——(77,879)——(77,879)
Other comprehensive (loss) income———68,759—68,759
Purchase of treasury stock————(47)(47)
Other——(2)—(1)(3)
Balance at September 30, 2026$2,729$1,357,891$13,251,498$(376,014)$(2,539,896)$11,696,208
Three Months Ended September 30, 2025
Balance at June 30, 2025$2,723$1,275,795$11,624,849$(406,401)$(2,108,294)$10,388,672
Net income——371,416——371,416
Shares issued——————
Issuance of common stock under employee stock plans—2,745——(195)2,550
Share-based compensation expense—12,916———12,916
Cash dividends paid——(71,410)——(71,410)
Other comprehensive (loss) income———(26,767)—(26,767)
Purchase of treasury stock————(150,501)(150,501)
Other——————
Balance at September 30, 2025$2,723$1,291,456$11,924,855$(433,168)$(2,258,990)$10,526,876

See accompanying notes.

AMETEK, Inc.

Consolidated Statement of Stockholders’ Equity (continued)

(In thousands)

(Unaudited)

Common stockCapital in excess of par valueRetained earningsAccumulated other comprehensive (loss) incomeTreasury stockTotal stockholders’ equity
Nine Months Ended September 30, 2026
Balance at December 31, 2025$2,725$1,317,288$12,252,480$(399,220)$(2,544,487)$10,628,786
Net income——1,232,553——1,232,553
Shares issued4————4
Issuance of common stock under employee stock plans—2,929——12,73915,668
Share-based compensation expense—37,674———37,674
Cash dividends paid——(233,530)——(233,530)
Other comprehensive (loss) income———23,206—23,206
Purchase of treasury stock————(8,147)(8,147)
Other——(5)—(1)(6)
Balance at September 30, 2026$2,729$1,357,891$13,251,498$(376,014)$(2,539,896)$11,696,208
Nine Months Ended September 30, 2025
Balance at December 31, 2024$2,720$1,264,670$11,057,684$(555,739)$(2,114,031)$9,655,304
Net income——1,081,541——1,081,541
Shares issued3————3
Issuance of common stock under employee stock plans—(8,443)——12,6194,176
Share-based compensation expense—35,229———35,229
Cash dividends paid——(214,370)——(214,370)
Other comprehensive (loss) income———122,571—122,571
Purchase of treasury stock————(157,578)(157,578)
Other——————
Balance at September 30, 2025$2,723$1,291,456$11,924,855$(433,168)$(2,258,990)$10,526,876

See accompanying notes.

AMETEK, Inc.

Condensed Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

Nine months ended September 30,
20262025
Cash provided by (used for):
Operating activities:
Net income$1,232,553$1,081,541
Adjustments to reconcile net income to total operating activities:
Depreciation and amortization327,054317,146
Deferred income taxes(45,631)(66,548)
Share-based compensation expense37,67435,229
Loss (Gain) on sale of facilities—(91)
Net change in assets and liabilities, net of acquisitions(44,483)(138,519)
Pension contributions(3,761)(4,529)
Other, net(7,549)(6,730)
Total operating activities1,495,8571,217,499
Investing activities:
Additions to property, plant and equipment(90,722)(73,251)
Purchases of businesses, net of cash acquired(5,345,848)(933,242)
Proceeds from sale of facilities—200
Other, net473521
Total investing activities(5,436,097)(1,005,772)
Financing activities:
Net change in short-term borrowings(447,689)427,684
Proceeds from long-term borrowings4,975,726—
Repayments of long-term borrowings(100,000)(239,942)
Repurchases of common stock(28,246)(163,623)
Cash dividends paid(233,530)(214,370)
Proceeds from stock option exercises28,14221,600
Debt financing costs(21,773)—
Other, net(14,588)(8,015)
Total financing activities4,158,042(176,666)
Effect of exchange rate changes on cash and cash equivalents(9,601)30,177
Increase (decrease) in cash and cash equivalents208,20165,238
Cash and cash equivalents:
Beginning of period457,951373,999
End of period$666,152$439,237

See accompanying notes.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

1. Basis of Presentation

The accompanying consolidated financial statements are unaudited. AMETEK, Inc. (the “Company”) believes that all adjustments (which primarily consist of normal recurring accruals) necessary for a fair presentation of the consolidated financial position of the Company at September 30, 2026, the consolidated results of its operations for the three and nine months ended September 30, 2026 and 2025 and its cash flows for the nine months ended September 30, 2026 and 2025 have been included. The Company has two reportable segments, Electronic Instruments Group (“EIG”) and Electromechanical Group (“EMG”). The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations. Quarterly results of operations are not necessarily indicative of results for the full year. The accompanying consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 as filed with the U.S. Securities and Exchange Commission.

2. Recent Accounting Pronouncements

Recent Accounting Pronouncements

In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815) - Hedge Accounting Improvements ("ASU 2025-09"). The amendments in this update aim to better align financial reporting with an entity's risk management strategies. It makes improvements in five key areas to help entities achieve and maintain hedge accounting for highly effective economic hedges. Improvements include changes to similar risk assessment for cash flow hedges, a new model for Choose-Your-Rate debt instruments, a principles-based approach for nonfinancial forecasted transactions, clarification on net written options, and addressing the mismatch in dual-hedge accounting. ASU 2025-09 is effective for annual periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. The adoption of ASU 2025-09 is not expected to impact the Company’s consolidated results of operations, financial position, cash flows or financial statement disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06) updating guidance on accounting for internal-use software. The amendments modernize guidance to consider different methods of software development, updating the requirements for capitalization of software costs. ASU 2025-06 is effective for annual and interim reporting periods beginning after December 15, 2027. Prospective, modified prospective, or retrospective application is allowed and early adoption is permitted. The Company has not determined the impact ASU 2025-06 may have on the Company’s consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income —Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional disclosures about significant expenses included in certain expense captions presented on the face of the income statement. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Prospective or retrospective application is allowed and early adoption is permitted. The Company has not determined the impact ASU 2024-03 may have on the Company’s financial statement disclosures.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

3. Revenues

The outstanding contract asset and liability accounts were as follows:

20262025
(In thousands)
Contract assets—January 1$159,896$136,432
Contract assets – September 30201,267173,363
Change in contract assets – increase (decrease)41,37136,931
Contract liabilities – January 1448,849400,689
Contract liabilities – September 30542,265466,983
Change in contract liabilities – (increase) decrease(93,416)(66,294)
Net change$(52,045)$(29,363)

The net change for the nine months ended September 30, 2026 was primarily driven by an increase in customer advance payments primarily from the acquisition of Indicor. For the nine months ended September 30, 2026 and 2025, the Company recognized revenue of $349.6 million and $276.7 million, respectively, that was previously included in the beginning balance of contract liabilities.

Contract assets are reported as a component of Other current assets in the consolidated balance sheet. At September 30, 2026 and December 31, 2025, $43.4 million and $52.7 million of Customer advanced payments (contract liabilities), respectively, were recorded in Other long-term liabilities in the consolidated balance sheets.

The remaining performance obligations not expected to be completed within one year as of September 30, 2026 and December 31, 2025 were $767.7 million and $627.4 million, respectively. Remaining performance obligations represent the transaction price of firm, non-cancelable orders, with expected delivery dates to customers greater than one year from the balance sheet date, for which the performance obligation is unsatisfied or partially unsatisfied. These performance obligations will be substantially satisfied within two to three years.

Geographic Areas

Net sales were attributed to geographic areas based on the location of the customer. Information about the Company’s operations in different geographic areas was as follows for the three and nine months ended September 30:

Three months ended September 30, 2026Nine months ended September 30, 2026
EIGEMGTotalEIGEMGTotal
(In thousands)
United States$695,980$463,438$1,159,418$1,969,933$1,275,003$3,244,936
International(1):
United Kingdom40,14537,45877,603102,078111,328213,406
European Union countries171,159127,822298,981496,268384,459880,727
Asia382,05693,409475,4651,042,307241,8181,284,125
Other foreign countries152,98155,858208,839417,424152,522569,946
Total international746,341314,5471,060,8882,058,077890,1272,948,204
Consolidated net sales$1,442,321$777,985$2,220,306$4,028,010$2,165,130$6,193,140

(1) Includes U.S. export sales of $653.8 million and $1,757.7 million for the three and nine months ended September 30, 2026, respectively.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

Three months ended September 30, 2025Nine months ended September 30, 2025
EIGEMGTotalEIGEMGTotal
(In thousands)
United States$605,310$381,254$986,564$1,761,703$1,087,397$2,849,100
International(1):
United Kingdom29,80037,51267,31285,356112,921198,277
European Union countries164,759116,401281,160442,678329,723772,401
Asia291,06366,741357,804855,893184,2001,040,093
Other foreign countries155,40044,401199,801403,946138,851542,797
Total international641,022265,055906,0771,787,873765,6952,553,568
Consolidated net sales$1,246,332$646,309$1,892,641$3,549,576$1,853,092$5,402,668

(1) Includes U.S. export sales of $512.8 million and $1,461.1 million for the three and nine months ended September 30, 2025.

Major Products and Services

The Company’s major products and services in the reportable segments were as follows:

Three months ended September 30, 2026Nine months ended September 30, 2026
EIGEMGTotalEIGEMGTotal
(In thousands)
Process and analytical instrumentation$1,041,379$—$1,041,379$2,876,974$—$2,876,974
Aerospace and power400,942233,901634,8431,151,036652,4141,803,450
Automation and engineered solutions—544,084544,084—1,512,7161,512,716
Consolidated net sales$1,442,321$777,985$2,220,306$4,028,010$2,165,130$6,193,140
Three months ended September 30, 2025Nine months ended September 30, 2025
EIGEMGTotalEIGEMGTotal
(In thousands)
Process and analytical instrumentation$883,483$—$883,483$2,463,220$—$2,463,220
Aerospace and power362,849189,893552,7421,086,356542,5241,628,880
Automation and engineered solutions—456,416456,416—1,310,5681,310,568
Consolidated net sales$1,246,332$646,309$1,892,641$3,549,576$1,853,092$5,402,668

Timing of Revenue Recognition

Three months ended September 30, 2026Nine months ended September 30, 2026
EIGEMGTotalEIGEMGTotal
(In thousands)
Products transferred at a point in time$1,166,165$691,737$1,857,902$3,233,344$1,909,192$5,142,536
Products and services transferred over time276,15686,248362,404794,666255,9381,050,604
Consolidated net sales$1,442,321$777,985$2,220,306$4,028,010$2,165,130$6,193,140

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

Three months ended September 30, 2025Nine months ended September 30, 2025
EIGEMGTotalEIGEMGTotal
(In thousands)
Products transferred at a point in time$993,386$576,933$1,570,319$2,819,874$1,674,371$4,494,245
Products and services transferred over time252,94669,376322,322729,702178,721908,423
Consolidated net sales$1,246,332$646,309$1,892,641$3,549,576$1,853,092$5,402,668

Product Warranties

The Company provides limited warranties in connection with the sale of its products. The warranty periods for products sold vary among the Company’s operations, but the majority do not exceed one year. The Company calculates its warranty expense provision based on its historical warranty experience and adjustments are made periodically to reflect actual warranty expenses. Product warranty obligations are reported as a component of accrued liabilities and other in the consolidated balance sheet.

Changes in the accrued product warranty obligation were as follows:

Nine Months Ended September 30,
20262025
(In thousands)
Balance at the beginning of the period$44,738$38,555
Accruals for warranties issued during the period12,79614,629
Settlements made during the period(13,446)(13,851)
Warranty accruals related to acquired businesses and other during the period2,9724,455
Balance at the end of the period$47,060$43,788

Accounts Receivable

The Company maintains allowances for estimated losses resulting from the inability of customers to meet their financial obligations to the Company. The Company recognizes an allowance for credit losses, on all accounts receivable and contract assets, which considers risk of future credit losses based on factors such as historical experience, contract terms, as well as general and market business conditions, country, and political risk. Balances are written off when determined to be uncollectible.

At September 30, 2026, the Company had $1,348.4 million of accounts receivable, net of allowances of $14.9 million. At December 31, 2025, the Company had $1,119.3 million of accounts receivable, net of allowance of $13.7 million. Changes in the allowance were not material for the three and nine months ended September 30, 2026.

4. Earnings Per Share

The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows:

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(In thousands)
Weighted average shares:
Basic shares229,159230,733229,049230,740
Equity-based compensation plans881937861821
Diluted shares230,040231,670229,910231,561

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

There were no antidilutive shares for the three and nine months ended September 30, 2026 and 2025.

5. Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The Company utilizes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the Company’s assets that are measured at fair value on a recurring basis, consistent with the fair value hierarchy, at September 30, 2026 and December 31, 2025:

September 30, 2026
TotalLevel 1Level 2Level 3
(In thousands)
Mutual fund investments$8,704$8,704$—$—
December 31, 2025
TotalLevel 1Level 2Level 3
(In thousands)
Mutual fund investments$8,199$8,199$—$—

The fair value of mutual fund investments is based on quoted market prices. The mutual fund investments are shown as a component of investments and other assets on the consolidated balance sheet.

For the nine months ended September 30, 2026 and 2025, gains and losses on the investments noted above were not significant. No transfers between level 1 and level 2 investments occurred during the nine months ended September 30, 2026 and 2025.

Financial Instruments

Cash, cash equivalents and mutual fund investments are recorded at fair value at September 30, 2026 and December 31, 2025 in the accompanying consolidated balance sheet.

The following table provides the estimated fair values of the Company’s financial instrument liabilities, for which fair value is measured for disclosure purposes only, compared to the recorded amounts at September 30, 2026 and December 31, 2025:

September 30, 2026December 31, 2025
Recorded AmountFair ValueRecorded AmountFair Value
(In thousands)
Long-term debt (including current portion)$(6,376,471)$(6,344,444)$(1,527,238)$(1,488,009)

The fair value of net short-term borrowings approximates the carrying value. The Company’s net long-term debt is all privately held with no public market for this debt, therefore, the fair value of net long-term debt was computed based on comparable current market data for similar debt instruments and is considered a level 3 liability.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

6. Hedging Activities

The Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations. As of September 30, 2026, these net investment hedges included British pound sterling-, Euro-, and Canadian dollar-denominated long-term debt. These borrowings are intended to offset translation gains and losses on the Company's net investments arising from changes in foreign currency exchange rates. The Company's hedge designations are supported by contemporaneous documentation maintained by management. Gains and losses on the designated debt instruments subsequent to hedge designation are recorded in Accumulated Other Comprehensive Income ("AOCI") as part of the foreign currency translation adjustment, consistent with the treatment of the related hedged net investments. Spot exchange rates are used to assess hedge effectiveness.

At September 30, 2026, the Company had $298.5 million of British pound sterling-denominated borrowings, $351.8 million of Canadian dollar-denominated borrowings and $1,276.2 million in Euro-denominated borrowings, designated as hedges of net investments in British pound sterling-, Canadian dollar-, and Euro-functional foreign subsidiaries. As a result of these net investment hedges, which were fully effective during the period, the Company recorded pre-tax foreign currency gains of $49.2 million in the foreign currency translation component of AOCI during the nine months ended September 30, 2026.

7. Inventories, net

September 30, 2026December 31, 2025
(In thousands)
Finished goods and parts$165,447$112,300
Work in process222,351179,792
Raw materials and purchased parts979,047814,313
Total inventories, net$1,366,845$1,106,405

8. Leases and Other Commitments

The Company has commitments under operating leases for certain facilities, vehicles and equipment used in its operations. Cash used in operations for operating leases was not materially different from operating lease expense for the nine months ended September 30, 2026 and 2025. The Company's leases have a weighted average remaining lease term of approximately six years.

The components of lease expense were as follows:

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(In thousands)
Operating lease cost$22,763$18,611$65,715$61,848
Variable lease cost4,0494,55111,85711,753
Total lease cost$26,812$23,162$77,572$73,601

Supplemental balance sheet information related to leases was as follows:

September 30, 2026December 31, 2025
(In thousands)
Right of use assets, net$284,603$273,142
Lease liabilities included in Accrued Liabilities and other73,64661,133
Lease liabilities included in Other long-term liabilities223,679227,066
Total lease liabilities$297,325$288,199

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

Maturities of lease liabilities as of September 30, 2026 were as follows:

Lease Liability Maturity AnalysisOperating Leases
(In thousands)
Remaining 2026$22,797
202777,844
202861,368
202949,226
203038,162
Thereafter94,700
Total lease payments344,097
Less: imputed interest46,772
$297,325

The Company does not have any significant leases that have not yet commenced.

Other Commitments

In the ordinary course of its business, the Company issues guarantees, stand-by letters of credit and surety bonds to provide financial or performance assurance to third parties on behalf of its consolidated subsidiaries to support or enhance the subsidiary's stand-alone creditworthiness. At September 30, 2026, the maximum amount of future payment obligations relative to these various guarantees was $518.0 million and the outstanding liability under certain of those guarantees was $193.9 million.

9. Acquisitions

The Company spent $5,345.8 million in cash, net of cash acquired, to acquire LKC Technologies ("LKC") in January 2026, First Aviation Services, Inc. ("First Aviation") in May 2026, and Indicor Instrumentation ("Indicor") in August 2026. LKC is a leading provider of innovative technologies to enable the effective diagnosis and management of ophthalmic conditions. LKC is part of EIG. First Aviation is a leading provider of highly engineered, mission-critical defense and aviation maintenance, repair and overhaul services and a manufacturer of related proprietary components. First Aviation has annual sales of approximately $80 million. First Aviation is part of EMG. Indicor is a collection of leading businesses that design and manufacture mission critical solutions for demanding industrial and scientific applications. Indicor has annual sales of approximately $1.1 billion. Indicor businesses are part of EIG and EMG based on product offerings and market alignment.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

The following table represents the allocation of the purchase price for the net assets of the LKC, First Aviation, and Indicor acquisitions based on the estimated fair values at acquisition (in millions):

IndicorOther AcquisitionsTotal
Property, plant and equipment$55.9$22.2$78.1
Goodwill2,698.5221.72,920.2
Other intangible assets2,454.1185.52,639.6
Deferred income taxes(380.7)(32.0)(412.7)
Net working capital and other(1)326.338.1364.4
Total purchase price$5,154.1$435.5$5,589.6
Less: Acquisition date fair value of cash acquired(232.7)(11.1)(243.8)
Total cash paid$4,921.4$424.4$5,345.8

(1)Includes $157.7 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal.

The amount allocated to goodwill is reflective of the benefits the Company expects to realize from the acquisitions. LKC's design and engineering capabilities complement the Company's existing ultra precision technologies business. First Aviation's proprietary products and services complement the Company's existing maintenance, repair and overhaul business. Indicor's products serve customers across end markets that closely align with the Company's existing portfolio of instrumentation businesses.

At September 30, 2026, the purchase price allocated to other intangible assets of $2,639.6 million consists of $374.2 million of indefinite-lived intangible trade names, which are not subject to amortization. The remaining $2,265.4 million of other intangible assets consists of $1,835.6 million of customer relationships, which are being amortized over a period of 17 to 20 years, and $429.8 million of purchased technology, which is being amortized over a period of 15 to 17 years. Amortization expense for each of the next five years for the 2026 acquisitions is expected to approximate $133 million per year.

The acquisitions had an immaterial impact on reported net sales, net income, and diluted earnings per share for the three and nine months ended September 30, 2026.

Unaudited pro forma information for the three and nine months ended September 30, 2026 and 2025 gives effect to the Indicor, LKC, and First Aviation acquisitions as if they had occurred as of January 1, 2025, including the results from operations for the acquired businesses. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time.

Had the Indicor, LKC, and First Aviation acquisitions been made at the beginning of 2026, unaudited pro forma net sales would have been approximately 8% and 11% higher than reported amounts for the three and nine months ended September 30, 2026, respectively. Had the acquisitions been made at the beginning of 2025, unaudited pro forma net sales would have been approximately 15% higher than reported amounts for the three and nine months ended September 30, 2025.

Unaudited pro forma net income and diluted earnings per share would not have been materially different than reported amounts for the three and nine months ended September 30, 2026 and 2025, considering the impacts of assumed financing of the transactions and the amortization of acquired intangible assets.

The Company finalized its measurements of tangible and intangible assets and liabilities, as well as the associated income tax considerations, for its July 2025 acquisition of FARO Technologies and its January 2026 acquisition of LKC and May 2026 acquisition of First Aviation, which had no material impact to the consolidated statement of income.

The initial accounting for the Indicor acquisition is incomplete, related to finalizing the measurement of the acquired tangible and intangible assets and liabilities. All amounts could change, potentially materially, as there is significant additional information that the Company must obtain to finalize the valuations of the tangible assets acquired and liabilities assumed, and to finalize the value of the intangible assets, primarily due to the proximity of the acquisition date to the balance sheet date of September 30, 2026. As of September 30, 2026, the Company is in the process of finalizing the tax valuations and purchase

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

price allocations across local tax jurisdictions. While a portion of the recorded goodwill is expected to be deductible for income tax purposes, the final allocation and exact tax-deductible goodwill amount cannot be reasonably estimated at this time.

In January 2025, the Company acquired Kern Microtechnik ("Kern"). The Kern acquisition included an $8.9 million estimated fair value contingent payment due upon Kern achieving certain cumulative revenue and EBITDA targets over the period January 1, 2025 to January 1, 2027. The contingent liability was based on a probabilistic approach using level 3 inputs. At September 30, 2026, we have adjusted the estimated fair value of the contingent payment liability to $10.5 million. For the three and nine months ended September 30, 2026, the change in the fair value of the contingent consideration liability was recorded in "Other (expense) income, net" in the consolidated statement of income.

10. Goodwill

The changes in the carrying amounts of goodwill by segment were as follows:

EIGEMGTotal
(In millions)
Balance at December 31, 2025$5,008.2$2,162.6$7,170.8
Goodwill acquired from 2026 acquisitions2,002.2918.02,920.2
Purchase price allocation adjustments and other83.5—83.5
Foreign currency translation adjustments25.310.936.2
Balance at September 30, 2026$7,119.2$3,091.5$10,210.7

11. Income Taxes

The effective tax rate for the three months ended September 30, 2026 was 18.3%, compared with 17.1% for the three months ended September 30, 2025. The lower effective tax rate in the third quarter of 2025 primarily reflects the remeasurement of deferred tax liabilities following the enactment of a lower corporate tax rate in Germany.

At September 30, 2026, the Company had gross uncertain tax benefits of $271.8 million, of which $219.9 million, if recognized, would impact the effective tax rate.

The following is a reconciliation of the liability for uncertain tax positions (in millions):

Balance at December 31, 2025$229.3
Additions for tax positions52.8
Reductions for tax positions(10.3)
Balance at September 30, 2026$271.8

The additions above primarily reflect the tax positions for foreign tax planning initiatives. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. The amounts recognized in income tax expense for interest and penalties during the three and nine months ended September 30, 2026 and 2025 were not significant.

The Organization for Economic Cooperation and Development’s (“OECD”) Pillar Two initiative set a 15% global minimum tax for certain multinationals, effective January 1, 2024, in most countries where the Company operates. In January 2026, new OECD guidance proposed a Side‑by‑Side (“SbS”) framework to limit Pillar Two taxes for U.S.-parented groups. Relief is contingent upon the implementation of the SbS framework within each respective jurisdiction's domestic legislation. As of September 30, 2026, the SbS regime had not been enacted in any significant jurisdictions, as a result the Company is accruing for all Pillar 2 tax exposures, including QDMTT, IIR, and UTPR. For the nine months ended September 30, 2026, the Company has recorded $12.5 million of top-up tax in its income tax expense, based on the currently enacted Pillar Two framework, in jurisdictions where the effective tax rate does not meet the 15% minimum threshold. The Company continues to monitor global legislative developments and will adjust financial reporting upon formal enactment in relevant jurisdictions.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

12. Debt

On June 9, 2026, the Company, along with certain of its foreign subsidiaries, entered into an amended and restated revolving credit agreement (the “Revolving Credit Agreement”) and a separate term loan credit agreement (the “Term Loan Agreement”). The Revolving Credit Agreement increased the aggregate commitments from $2.3 billion to $3.5 billion and extended the maturity to June 9, 2031. The facility is subject to customary financial and restrictive covenants and may be used for general corporate purposes, including working capital, debt refinancing, and up to $1.0 billion to fund a portion of the consideration for the previously announced acquisition of Indicor. In the third quarter of 2026, the Company borrowed 550 million Euros and 500 million Canadian dollars under its revolving credit agreement. The revolver bears interest at variable rates and matures in June 2031. At September 30, 2026, the Company had $975.7 million borrowings outstanding under the revolver.

The Term Loan Agreement provides for a senior unsecured term loan facility of up to $4.0 billion, consisting of three tranches: $1.625 billion maturing three years after funding, $1.625 billion maturing four years after funding, and $750 million maturing five years after funding. In the third quarter of 2026, the Company borrowed $4.0 billion in three tranches to fund the Indicor acquisition. At September 30, 2026, the Company had $4.0 billion borrowings outstanding under the term loans.

Both agreements contain customary affirmative and negative covenants, financial maintenance covenants, and events of default. Borrowings under the facilities bear interest at variable rates based on either a secured overnight financing rate (“SOFR”) or an alternate base rate, in each case plus an applicable margin determined by reference to the Company’s credit rating or leverage. The Company may prepay borrowings at any time without premium or penalty, subject to customary breakage costs.

In connection with entering into the purchase agreement for the Indicor acquisition, the Company previously obtained $5.0 billion in bridge financing commitments. Upon execution of the Revolving Credit Agreement and the Term Loan Agreement, these bridge commitments were automatically reduced and terminated in full.

At September 30, 2026, the Company had $306.0 million outstanding under its commercial paper program.

In the third quarter of 2026, the Company paid in full, at maturity, a $100.0 million in aggregate principal amount of 3.83% senior notes.

13. Share-Based Compensation

The Company's share-based compensation plans are described in Note 11, Share-Based Compensation, to the consolidated financial statements in Part II, Item 8, filed on the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Share Based Compensation Expense

Total share-based compensation expense was as follows:

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(In thousands)
Stock option expense$2,647$2,830$8,022$8,946
Restricted stock expense5,9705,44317,14615,768
Performance restricted stock unit expense5,4574,64312,50610,515
Total pre-tax expense$14,074$12,916$37,674$35,229

Pre-tax share-based compensation expense is included in the consolidated statement of income in either Cost of sales or Selling, general and administrative expenses, depending on where the recipient’s cash compensation is reported.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

Stock Options

The fair value of each stock option grant is estimated on the grant date using a Black-Scholes-Merton option pricing model. The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:

Nine Months Ended September 30, 2026Year Ended December 31, 2025
Expected volatility20.1%22.7%
Expected term (years)5.05.0
Risk-free interest rate3.87%4.07%
Expected dividend yield0.64%0.70%
Black-Scholes-Merton fair value per stock option granted$51.29$46.21

The following is a summary of the Company’s stock option activity and related information:

SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual LifeAggregate Intrinsic Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20251,950$126.07
Granted234212.77
Exercised(244)114.51
Forfeited(35)186.61
Outstanding at September 30, 20261,905$137.095.9$210.8
Exercisable at September 30, 20261,466$119.615.0$187.8

The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2026 was $29.2 million. The total fair value of stock options vested during the nine months ended September 30, 2026 was $11.7 million. As of September 30, 2026, there was approximately $16.1 million of expected future pre-tax compensation expense related to the 0.5 million non-vested stock options outstanding, which is expected to be recognized over a weighted average period of approximately two years.

Restricted Stock

The following is a summary of the Company’s non-vested restricted stock activity and related information:

SharesWeighted Average Grant Date Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2025280$173.25
Granted144213.99
Vested(126)167.52
Forfeited(26)188.19
Non-vested restricted stock outstanding at September 30, 2026272$196.04

The total fair value of restricted stock vested during the nine months ended September 30, 2026 was $21.1 million. As of September 30, 2026, there was approximately $38.8 million of expected future pre-tax compensation expense related to

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

the 0.3 million non-vested restricted shares outstanding, which is expected to be recognized over a weighted average period of approximately two years.

Performance Restricted Stock Units

The following is a summary of the Company’s non-vested performance restricted stock activity and related information:

SharesWeighted Average Grant Date Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2025240$166.06
Granted79212.77
Performance assumption change 12138.46
Vested(77)138.46
Forfeited(6)185.47
Non-vested performance restricted stock outstanding at September 30, 2026238$189.77

1 Reflects the number of PRSUs above target levels based on performance metrics.

As of September 30, 2026, there was approximately $12.1 million of expected future pre-tax compensation expense related to the 0.2 million non-vested restricted shares outstanding, which is expected to be recognized over a weighted average period of less than one year.

14. Retirement and Pension Plans

The components of net periodic pension benefit expense (income) were as follows:

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(In thousands)
Defined benefit plans:
Service cost$503$603$1,514$1,771
Interest cost7,1197,35621,37221,856
Expected return on plan assets(14,445)(13,259)(43,339)(39,589)
Amortization of net actuarial loss and other1,4712,0744,4126,159
Pension income(5,352)(3,226)(16,041)(9,803)
Other plans:
Defined contribution plans13,07010,38339,66934,074
Foreign plans and other1,7961,5695,3974,557
Total other plans14,86611,95245,06638,631
Total net pension expense$9,514$8,726$29,025$28,828

For defined benefit plans, the net periodic benefit income, other than the service cost component, is included in “Other (expense) income, net” in the consolidated statement of income.

For the nine months ended September 30, 2026 and 2025, contributions to the Company’s defined benefit pension plans were $3.8 million and $4.5 million, respectively. The Company’s current estimate of 2026 contributions to its worldwide defined benefit pension plans is in line with the range disclosed in Note 12 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

15. Contingencies

Asbestos Litigation

The Company (including its subsidiaries) has been named as a defendant in a number of asbestos-related lawsuits. Certain of these lawsuits relate to a business which was acquired by the Company and do not involve products which were manufactured or sold by the Company. In connection with these lawsuits, the seller of such business has agreed to indemnify the Company against these claims (the “Indemnified Claims”). The Indemnified Claims have been tendered to, and are being defended by, such seller. The seller has met its obligations, in all respects, and the Company does not have any reason to believe such party would fail to fulfill its obligations in the future. To date, no judgments have been rendered against the Company as a result of any asbestos-related lawsuit. The Company believes that it has good and valid defenses to each of these claims and intends to defend them vigorously.

Environmental Matters

Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At September 30, 2026, the Company is named a Potentially Responsible Party (“PRP”) at 13 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned” sites). The Company is identified as a “de minimis” party in a majority of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. The Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the best estimate. It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations.

Total environmental reserves at September 30, 2026 and December 31, 2025 were $39.5 million and $37.4 million, respectively, for both non-owned and owned sites. For the nine months ended September 30, 2026, the Company recorded $8.8 million in reserves. Additionally, the Company spent $6.7 million on environmental matters for the nine months ended September 30, 2026.

The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of these other parties also carry insurance coverage for some environmental matters.

The Company believes it has established reserves for the environmental matters described above, which are sufficient to perform all known responsibilities under existing claims and consent orders. In the opinion of management, based on presently available information and the Company’s historical experience related to such matters, an adequate provision for probable costs has been made and the ultimate cost resulting from these actions is not expected to materially affect the consolidated results of operations, financial position or cash flows of the Company.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

16. Reportable Segments

The Company has two reportable segments, Electronic Instruments Group and Electromechanical Group. The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations.

Reportable Segment Financial Information (in thousands):

Three Months Ended September 30, 2026
EMGEIGCorporateTotal Consolidated
Net Sales$777,985$1,442,321$—$2,220,306
Cost of sales (1)541,090868,782—1,409,872
Selling expense26,886166,796—193,682
Segment Operating Income210,009406,743—616,752
Corporate G&A——31,80331,803
Operating Income210,009406,743(31,803)584,949
Interest expense——(39,822)(39,822)
Other (expense) income, net (2)——(23,212)(23,212)
Income before Income Taxes$210,009$406,743$(94,837)$521,915
Depreciation14,82619,2291,47935,534
Amortization21,80558,294—80,099
Total depreciation and amortization$36,631$77,523$1,479$115,633
Research, Development & Engineering costs (3)$22,979$82,437$—$105,416
Assets$6,696,443$14,819,458$872,634$22,388,535
Capital Expenditures$9,227$16,931$7,085$33,243

(1)Includes $9.8 million of acquisition-related integration costs.

(2)Includes $18.1 million of acquisition-related transaction costs.

(3)Included in cost of sales.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

Three Months Ended September 30, 2025
EMGEIGCorporateTotal Consolidated
Net Sales$646,309$1,246,332$—$1,892,641
Cost of sales (1)460,061746,444—1,206,505
Selling expense22,373147,451—169,824
Segment Operating Income163,875352,437—516,312
Corporate G&A——27,93227,932
Operating Income163,875352,437(27,932)488,380
Interest expense——(22,514)(22,514)
Other (expense) income, net (2)——(17,901)(17,901)
Income before Income Taxes$163,875$352,437$(68,347)$447,965
Depreciation$14,964$19,409$1,407$35,780
Amortization18,71148,587—67,298
Total depreciation and amortization$33,675$67,996$1,407$103,078
Research, Development & Engineering costs (3)$19,995$74,686$—$94,681
Assets$4,837,524$10,717,580$627,153$16,182,257
Capital Expenditures$7,929$12,984$—$20,913

(1)Includes $7.8 million of acquisition-related integration costs.

(2)Includes $12.0 million of acquisition-related transaction costs.

(3)Included in cost of sales.

Nine Months Ended September 30, 2026
EMGEIGCorporateTotal Consolidated
Net Sales$2,165,130$4,028,010$—$6,193,140
Cost of sales (1)1,520,3072,409,799—3,930,106
Selling expense74,731467,808—542,539
Segment Operating Income570,0921,150,403—1,720,495
Corporate G&A——92,41792,417
Operating Income570,0921,150,403(92,417)1,628,078
Interest expense (2)——(90,832)(90,832)
Other (expense) income, net (3)——(29,979)(29,979)
Income before Income Taxes$570,092$1,150,403$(213,228)$1,507,267
Depreciation$46,004$57,824$4,771$108,599
Amortization59,019159,436—218,455
Total depreciation and amortization$105,023$217,260$4,771$327,054
Research, Development & Engineering costs (4)$67,609$260,304$—$327,913
Capital Expenditures$29,479$45,447$15,796$90,722

(1)Includes $27.6 million of acquisition-related integration costs.

(2)Includes $10.0 million of acquisition-related financing fees.

(3)Includes $18.1 million of acquisition-related transaction costs.

AMETEK, Inc.

Notes to Consolidated Financial Statements

September 30, 2026

(Unaudited)

(4)Included in cost of sales.

Nine Months Ended September 30, 2025
EMGEIGCorporateTotal Consolidated
Net Sales$1,853,092$3,549,576$—$5,402,668
Cost of sales (1)1,349,9812,105,662—3,455,643
Selling expense66,630392,999—459,629
Segment Operating Income436,4811,050,915—1,487,396
Corporate G&A——82,56182,561
Operating Income436,4811,050,915(82,561)1,404,835
Interest expense——(58,364)(58,364)
Other (expense) income, net (2)——(22,115)(22,115)
Income before Income Taxes$436,481$1,050,915$(163,040)$1,324,356
Depreciation$46,022$57,296$4,324$107,642
Amortization72,166137,338—209,504
Total depreciation and amortization$118,188$194,634$4,324$317,146
Research, Development & Engineering costs (3)$62,270$221,503$—$283,773
Capital Expenditures$25,286$34,653$13,312$73,251

(1)Includes $7.8 million of acquisition-related integration costs.

(2)Includes $12.0 million of acquisition-related transaction costs.

(3)Included in cost of sales.

Previous: Cover and table of contents · Next: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations